"Blood Safety" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The degree to which the blood supply for BLOOD TRANSFUSIONS is free of harmful substances or infectious agents, and properly typed and crossmatched (BLOOD GROUPING AND CROSSMATCHING) to insure serological compatibility between BLOOD DONORS and recipients.
Descriptor ID |
D058731
|
MeSH Number(s) |
E02.792.833.230.500 E05.760.833.230.500 N06.850.780.200.450.325
|
Concept/Terms |
Blood Safety- Blood Safety
- Safety, Blood
- Blood Supply Safety
- Blood Supply Safeties
- Safety, Blood Supply
|
Below are MeSH descriptors whose meaning is more general than "Blood Safety".
Below are MeSH descriptors whose meaning is more specific than "Blood Safety".
This graph shows the total number of publications written about "Blood Safety" by people in this website by year, and whether "Blood Safety" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2018 | 1 | 0 | 1 |
2019 | 0 | 1 | 1 |
2021 | 1 | 0 | 1 |
2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Blood Safety" by people in Profiles.
-
Iannone A, Cumming M, Osinski A, Brandeburg C, Schultz J, Slider A, Rodrigue B, O'Hearn L, Herman M, McHale E, Rios J, Uhl L, Andrzejewski C, DeMaria A. How do we use the National Healthcare Safety Network for Hemovigilance in Massachusetts? Transfusion. 2024 02; 64(2):200-209.
-
Mowla SJ, Kracalik IT, Sapiano MRP, O'Hearn L, Andrzejewski C, Basavaraju SV. A Comparison of Transfusion-Related Adverse Reactions Among Apheresis Platelets, Whole Blood-Derived Platelets, and Platelets Subjected to Pathogen Reduction Technology as Reported to the National Healthcare Safety Network Hemovigilance Module. Transfus Med Rev. 2021 04; 35(2):78-84.
-
Wiersum-Osselton JC, Whitaker B, Grey S, Land K, Perez G, Rajbhandary S, Andrzejewski C, Bolton-Maggs P, Lucero H, Renaudier P, Robillard P, Santos M, Schipperus M. Revised international surveillance case definition of transfusion-associated circulatory overload: a classification agreement validation study. Lancet Haematol. 2019 Jul; 6(7):e350-e358.
-
Edens C, Haass KA, Cumming M, Osinski A, O'Hearn L, Passanisi K, Eaton L, Visintainer P, Savinkina A, Kuehnert MJ, Basavaraju SV, Andrzejewski C. Evaluation of the National Healthcare Safety Network Hemovigilance Module for transfusion-related adverse reactions in the United States. Transfusion. 2019 02; 59(2):524-533.
-
Goss C, Giardina P, Degtyaryova D, Kleinert D, Sheth S, Cushing M. Red blood cell transfusions for thalassemia: results of a survey assessing current practice and proposal of evidence-based guidelines. Transfusion. 2014 Jul; 54(7):1773-81.
-
Vichinsky E, Neumayr L, Trimble S, Giardina PJ, Cohen AR, Coates T, Boudreaux J, Neufeld EJ, Kenney K, Grant A, Thompson AA. Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME). Transfusion. 2014 Apr; 54(4):972-81; quiz 971.